Business · 25/04/2022Updated: 10/17/2026 · 1 min read
Baxter Healthcare Corporation, et al.; FDA Withdraws Approval of 14 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 14 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →